Catalyst Wire Dossier Catalyst Wire Dossier

High-dose ascorbate

ascorbic acid
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for High-dose ascorbate, covering 2026-07-23 to 2026-07-23. Get the full timeline:

Most recent: Clinical Trial Results: A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) [Phase 2]

See pricing